The global market for biopsy
devices is expected to reach USD 2,335.1 million by 2020 growing at a CAGR of
6.4%, according to a new study by Grand View Research, Inc. Growing global
prevalence of cancer, geriatric population and increasing demand for minimally
invasive procedures are expected to drive market growth during the forecast
period. Other drivers of this market include the introduction of technological
advancements such as robotic biopsy guidance systems and healthcare reforms
pertaining to reimbursement policies. Growing patient awareness levels and the
presence of high unmet medical needs in emerging markets such as India and
China are also expected to fuel future growth of the market.
Biopsy guidance systems
dominated the overall market in terms of share at over 40% in 2013. Growing
demand for user friendly, relatively smaller and semi-automatically operated
devices and the introduction of technological advancements such as robotic
guidance systems are some of the major factors attributing to its large share.
Request to Sample of This Report @ http://www.grandviewresearch.com/industry-analysis/biopsy-devices-industry
Further key findings from the study
suggest:
- North America dominated the market with a revenue share of over 60.0% in 2013 owing to the presence of sophisticated healthcare infrastructure, reimbursement framework, high healthcare expenditures and growing prevalence of cancer.
- Europe followed North America in terms of revenue share in 2013 on account of the presence of high patient awareness levels in Western European countries and the presence of large untapped opportunities in Eastern Europe.
- Asia Pacific is expected to grow at the highest CAGR of over 10.0% during the forecast period. Presence of high unmet medical needs, growing healthcare expenditures and a constantly improving healthcare infrastructure in emerging markets of India and China are some of the factors accounting for its rapid growth.
- Key market players include C.R Bard, Care Fusion Corporation, Hologic Inc., Devicor Medical Products Inc., DTR medical, Angiotech, UK Biopsy, Cardinal Healthcare Inc. and INRAD Inc.
For the purpose of this study, Grand View Research has
segmented the global biopsy devices market on the basis of products and region:
About Grand View
Research
Grand View Research, Inc. is a U.S. based market research and
consulting company, registered in the State of California and headquartered in
San Francisco. The company provides syndicated research reports, customized
research reports, and consulting services. To help clients make informed
business decisions, the company offers market intelligence studies ensuring
relevant and fact-based research across a range of industries including
technology, chemicals, materials, healthcare and energy.
For More Information,
Visit Grand
View Research
Contact:
Sherry James
Corporate Sales Specialist, U.S.A.
Grand View Research, Inc.
United States
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email:
sales@grandviewresearch.com
Blog Site: http://www.grandviewresearchinc.blogspot.in/
No comments :
Post a Comment